Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Nasopharyngeal Squamous Cell Carcinoma; Locally Advanced Oral Cavity Squamous Cell Carcinoma; Local ly Advanced Oropharyngeal Squamous Cell Carcinoma; Malignant Posterior Tongue Neoplasm; Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8; Stage II Hypopharyngeal Carcinoma AJCC v8; Stage II Laryngeal Cancer AJCC v8; Stage II Nasopharyngeal Carcin oma AJCC v8; ...
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Conditions: Head and Neck Squamous Cell Carcinoma; HNSCC; Squamous Cell Carcinoma of the Larynx; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of Hypopharynx Intervention: Drug: Cemiplimab-Rwlc Sponsors: University of Miami; Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials
